Ceramides
are composed of a sphingosine and a single fatty acid
connected by an amide linkage. As one of the major classes of biologically
active lipids, ceramides and their upstream and downstream metabolites
have been implicated in several pathological conditions including
cancer, neurodegeneration, diabetes, microbial pathogenesis, obesity,
and inflammation. Consequently, tremendous efforts have been devoted
to deciphering the dynamics of metabolic pathways involved in ceramide
biosynthesis. Given that several distinct enzymes can produce ceramide,
different enzyme targets have been pursued depending on the underlying
disease mechanism. The main objective of this review is to provide
a comprehensive overview of small molecule inhibitors reported to
date for each of these ceramide-producing enzymes from a medicinal
chemistry perspective.